Hypha Labs
Available for OEM Licensing

Helium-Free MRI Magnet. Built for the next generation of whole-body MRI.

A cryogen-free superconducting magnet platform that eliminates liquid-helium infrastructure, cuts lifetime operating cost, and decouples OEM supply chains from the tightening global helium market. Patent pending — licensing conversations open.

18 Patent filings in progress
3 Research domains
2026 Founded, Seattle WA
NEW AI-Powered Genetic Engineering Design Platform

Hypha Lab

End-to-end GMO design from sequence retrieval to patent-ready ST.26 exports.

Let the AI generate complete design proposals with built-in tools for fetching sequences, building constructs, codon optimization, and seamless patent exports. The DNA Alteration Rating system gives you instant clarity on how much a sequence has been optimized from the original. Built for researchers who need precision in genetic engineering.

Start Designing → Licensing Inquiries →
Key Capabilities
Sequence Retrieval
Construct Builder
Codon Optimization
ST.26 Patent Export
NEW Patent Pending — App. 19/684,949 Filed May 22, 2026

Split-Witness

The zero-knowledge proof has a memory problem. Split-Witness solves it.

ZK proofs are powerful but run into a fundamental wall: the prover's memory scales with circuit size. Split-Witness splits the proof generation across the trusted execution environment and the host — eliminating the memory bottleneck for complex circuits. Practical for real-world applications at scale, not just academic benchmarks.

Core Technology
TEE Partitioning
Memory-Bound Proofs
Circuit Efficiency
Trusted Execution Env.
Patent Pending — App. 64/069,823 Filed May 19, 2026

Verifiable Threat Intelligence Fusion

A cryptographic architecture for fusing multi-source threat data into a tamper-evident intelligence picture. Hardware-bound ZK proofs verify provenance. Byzantine consensus ensures no actor can corrupt the output. Post-quantum resistant.

Key Tech
ZK Proofs
Byzantine Consensus
Distributed Ledger
TEE Attestation
Patent Pending Provisional application · Filed 2026

HTS Cryogen-Free Superconducting Magnet Platform for Whole-Body MRI

A cryogen-free superconducting magnet platform designed for next-generation whole-body MRI systems. The closed-cycle architecture holds operating temperature without continuous helium top-offs, changing siting economics, supply-chain risk, and total lifetime cost posture for OEM product teams.

Key Technology
Cryogen-Free
Whole-Body MRI
Closed-Cycle Cooling
Helium Independent
Patent Pending — App. 64/055,368 Filed 2025 Biological Materials

Whale Oil Wax Esters

A novel class of bio-derived structural thermoset polymers from whale oil wax esters. High crosslink density, thermal stability to 350°C+, mechanical properties competitive with high-performance epoxies. Renewable pathway for aerospace, marine, and industrial coatings.

Properties
Thermoset Resins
350°C+ Stable
Bio-derived
Aerospace Grade

Two core domains. One emerging portfolio.

Our R&D pipeline concentrates on biological materials and advanced propulsion — two areas where novel fundamental discoveries translate into defensible, long-term IP. A third category captures promising work that sits outside either main domain.

See full portfolio →

Biological Materials

Novel materials derived from biological systems and processes. Five patent filings covering properties, synthesis methods, and applications.

5 filings

Advanced Propulsion

Propulsion system concepts and related engineering innovations. Ten patent filings spanning designs, mechanisms, and enabling technologies.

10 filings

Other Technologies

Promising innovations outside our primary domains. Three additional patent filings that extend the portfolio's technical breadth.

3 filings

Clean transactions. Direct engagement.

No intermediaries, no lengthy procurement processes. We work directly with qualified organizations on both licensing and outright acquisition.

01

Portfolio Review

Request documentation on specific technology areas. We'll share relevant filings and technical abstracts with qualified inquirers.

02

Licensing

Negotiate terms for use of one or more patents. Exclusive and non-exclusive arrangements available depending on the technology and market.

03

Acquisition

Purchase outright ownership of individual patents or related groups. We work with qualified buyers on a straightforward, case-by-case basis.

Interested in our research pipeline?

Tell us your organization and the technology area you're exploring. We respond to all substantive inquiries.

Contact Hypha Labs